Intco Medical Technology Co Ltd
SZSE:300677
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
17.76
33.61
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intco Medical Technology Co Ltd
Total Liabilities
Intco Medical Technology Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Liabilities
ÂĄ14.6B
|
CAGR 3-Years
43%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
||
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Liabilities
ÂĄ11.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
||
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Total Liabilities
ÂĄ932.2m
|
CAGR 3-Years
98%
|
CAGR 5-Years
92%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Liabilities
ÂĄ2.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Total Liabilities
ÂĄ5.6B
|
CAGR 3-Years
30%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Liabilities
ÂĄ678.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
Intco Medical Technology Co Ltd
Glance View
Intco Medical Technology Co., Ltd. engages in the supply of comprehensive medical care product. The company is headquartered in Zibo, Shandong and currently employs 9,115 full-time employees. The company went IPO on 2017-07-21. The firm's main products include medical care products, rehabilitation care products, health care products and inspection supplies, such as disposable gloves, wheelchairs, hot and cold compresses and electrode sheets. Its products are mainly used in medical institutions, pension care institutions, household commodity and other related industries. The firm distributes its products in domestic market and to overseas markets.
See Also
What is Intco Medical Technology Co Ltd's Total Liabilities?
Total Liabilities
14.6B
CNY
Based on the financial report for Sep 30, 2024, Intco Medical Technology Co Ltd's Total Liabilities amounts to 14.6B CNY.
What is Intco Medical Technology Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
62%
Over the last year, the Total Liabilities growth was 59%. The average annual Total Liabilities growth rates for Intco Medical Technology Co Ltd have been 43% over the past three years , 62% over the past five years .